𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II trial of cisplatin, 5-fluorouracil, and interferon-α-2B as first line treatment of advanced urothelial cancer

✍ Scribed by Shouki Bazarbashi; Chandrashaker Pai; Madras A Raja; Mohammad Rahal; Adnan Ezzat; Kamal Hanash

Book ID
117724214
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
72 KB
Volume
21
Category
Article
ISSN
1078-1439

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of 5-fluorouracil, leucov
Phase II trial of 5-fluorouracil, leucovorin, interferon-α-2a, and cisplatin as neoadjuvant chemotherapy for locally advanced esophageal carcinoma
✍ Barbara K. Temeck; James E. Liebmann; Christopher Theodossiou; Seth M. Steinberg 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 635 KB

## BACKGROUND. Most patients with esophageal carcinoma present with locally advanced disease and a poor prognosis. Surgery or radiation provides palliation for locally advanced esophageal carcinoma. The role of neoadjuvant therapy remains to be defined. We administered neoadjuvant chemotherapy cons

Phase II clinical trial with 5-fluoroura
Phase II clinical trial with 5-fluorouracil, recombinant interferon-α-2b, and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagus
✍ Scott Wadler; Hilda Haynes; Jonathan J. Beitler; Xiaoping Hu; Stanley Fell; Marg 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 393 KB 👁 1 views

## Background: Recombinant interferon-alpha (ifn) augments the cytotoxicity of both 5-fluorouracil (5-fu) and cisplatin in vitro. a phase ii study of 5-fu and ifn resulted in response rates of 25-27% in patients with metastatic esophageal carcinoma. ## Methods: A phase ii trial was initiated to d